Related Experiment Videos
Primary hemostasis after massive transfusion for injury
The American Surgeon
|August 1, 1982
Summary
Massive transfusions in injured patients can cause low platelet counts (PLT) and prolonged bleeding time (BT), indicating platelet dysfunction. This dysfunction may offer protection against disseminated intravascular coagulation.
Area of Science:
- Transfusion Medicine
- Hematology
- Trauma Surgery
Background:
- Primary hemostasis, crucial for controlling bleeding, relies on platelet plug formation.
- Massive transfusions are often required to manage bleeding in severely injured patients.
- The impact of stored blood transfusions on platelet function and bleeding time is not fully understood.
Purpose of the Study:
- To investigate platelet counts (PLT) and bleeding time (BT) in injured patients undergoing massive transfusions.
- To correlate PLT and BT levels with transfusion volume and storage duration of transfused blood.
- To assess the potential protective role of transfusion-induced platelet dysfunction against disseminated intravascular coagulation (DIC).
Main Methods:
- Prospective study of 22 injured patients receiving an average of 21 transfusions.
- Serial measurements of PLT and BT intraoperatively and postoperatively (6h, 25h, day 2, day 4, convalescence).
- Correlation analysis between PLT/BT and transfusion parameters (number, storage age).
Main Results:
- Intraoperative PLT dropped to 109,000/mm3 with BT > 15 minutes.
- Postoperative PLT significantly decreased to 73,000/mm3 at 15 hours and 76,000/mm3 on day 2.
- PLT normalized by day 4 (110,000/mm3) and became supernormal during convalescence.
- BT remained prolonged until day 4, normalizing during convalescence.
- Thrombocytopenia and prolonged BT did not correlate with transfusion number or blood storage age.
Conclusions:
- Massive transfusion in injured patients leads to significant thrombocytopenia and prolonged bleeding time, indicative of platelet dysfunction.
- This platelet dysfunction may serve a protective role against the development of disseminated intravascular coagulation.
- Intervention for thrombocytopenia should be reserved for actively bleeding patients.